Search

Search Constraints

You searched for: Author/Creator Andersen, Niels Frost

Search Results

1. A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk. Issue 2 (1st October 2022)

2. Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study. Issue 6 (June 2020)

3. Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study. Issue 6 (June 2020)

4. Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group. (11th October 2021)

5. Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients. Issue 2 (30th March 2021)

6. Inotropic myocardial reserve deficiency is the predominant feature of exercise haemodynamics in cardiac amyloidosis. (24th August 2017)

8. Myocardial Oxygen Consumption and Efficiency in Patients With Cardiac Amyloidosis. Issue 21 (6th November 2018)

9. The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population‐based study. (22nd June 2017)